Applied Clinical Trials-10-01-2017

October 01, 2017

Vienna joins growing list of bidders to land Europe's drug regulator; Amsterdam the early favorite?

October 01, 2017

New legislation aims to expand regulatory acceptance of patient data from healthcare systems and observational studies.

October 01, 2017

New safety review of epilespy treatment puts spotlight on issues such as communication between regulators and prescribers.

October 01, 2017

PV experts face new challenges as focus in field moves toward acting on real-world evidence insights.  

October 01, 2017

Q&A explores the evolution of the patient-centric supply chain and how it's poised to impact the clinical trials landscape.

October 01, 2017

Recent study, and others in literature, inform misconceptions around physician and nurse involvement in clinical trials. 

October 01, 2017

Supply chain strategies require a close look at the regulatory factors and the drug import hurdles and hopes in the region.

October 01, 2017

Automation will be key to improving efficiency and mitigating risk during the complex process of cell therapy production and delivery.

October 01, 2017

How a single-source temperature management strategy can support a drug’s quality and integrity in transit-a process as important as the destination.

October 01, 2017

Outlining a decision-making framework that integrates real-world signals with supply planning techniques to reduce risk and avoid potential interruptions.

October 01, 2017

Learn to partner effectively in the era of collaboration, where the benefits gained will outweigh the challenges if approached correctly

October 01, 2017

The key to moving legacy systems-electronic or paper-to the cloud: Do it in doses-and learn from those who went before.

September 01, 2017

Click the title above to open the Applied Clinical Trials September/October 2017 issue in an interactive PDF format.